Poster Session 4
Category: Hypertension
Poster Session 4
Miriam Hankins, MD, MS (she/her/hers)
MFM Fellow
University of Mississippi Medical Center
Jackson, Mississippi, United States
Nathan Campbell, PhD
Instructor
University of Mississippi Medical Center
Jackson, Mississippi, United States
Jane J. Border, MS
University of Mississippi Medical Center
Jackson, Mississippi, United States
Murphy Lemon
University of Mississippi Medical Center
Jackson, Mississippi, United States
E. Hawthorne Cleveland, BS
University of Mississippi Medical Center
Jackson, Mississippi, United States
Baoying Zheng, MS
University of Mississippi Medical Center
Jackson, Mississippi, United States
Alexandra Demesa, MS
University of Mississippi Medical Center
Jackson, Mississippi, United States
Evangeline Deer, PhD (she/her/hers)
Instructor
University of Mississippi Medical Center
Jackson, Mississippi, United States
Rachael Morris, MD
Associate Professor
University of Mississippi Medical Center
Jackson, Mississippi, United States
Richard R. Roman, PhD
University of Mississippi Medical Center
Jackson, Mississippi, United States
Babbette LaMarca, PhD
University of Mississippi Medical Center
Jackson, Mississippi, United States
Preeclampsia (PE), new-onset hypertension in pregnancy, is associated with immune activation, B cells secreting agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA), and neurological complications. We have shown AT1-AA to contribute to neurovascular dysfunction during pregnancy and we know that it is produced postpartum up to 7 years, suggesting a memory B cell immune response. Therefore, we hypothesize that CD20+ B cells cause hypertension and neurovascular dysfunction that allows for transmission of high blood pressure to the brain via AT1-AA.
Study Design:
Three hundred thousand placental CD20+ B Cells from normal pregnant (NP) or PE patients were isolated at delivery and injected i.p. into nude athymic rats on gestational day (GD) 12. Mini-osmotic pumps containing the AT1-AA inhibitor peptide, ‘n7AAc’, were inserted on GD14. Between GD14 and GD19 memory and learning were assessed with a Barnes maze. On GD19, blood pressure (MAP) and cerebral blood flow (CBF) autoregulation were measured with laser doppler flowmetry (LDF). A one-way ANOVA was used for statistical analysis.
Results:
MAP increased in PE B cell recipients (123±2 mmHg, n=8) compared to NP recipients (106±3 mmHg, n=11). MAP was lowered with ‘n7AAc’ to 110±3 mmHg (n=6). AT1-AA activity was elevated with PE B cells to 14±2 ΔBPM, n=6 compared to NP recipients (2±1 ΔBPM, n=5) and ‘n7AAc’ treated PE recipients (1±2 ΔBPM, n=6). Baseline CBF was significantly higher in PE recipients (569±63 LDF, n=3) compared to NP recipients (252±13 LDF, n=3) or ‘n7AAc’ treated PE recipients (317±58 LDF, n=3). CBF autoregulation was improved in ‘n7AAc’ treated PE recipients (43±4% increased transmission, n=3) compared to PE recipients (66±10% increased transmission, n=3). Over five days, PE recipients were slower to escape the Barnes maze than NP B cell recipients or ‘n7AAc’ treated PE B cell recipients.
Conclusion:
CD20+ B cells from PE women contribute to hypertension, AT1-AA and neurovascular and cognitive dysfunction during pregnancy supporting a role for B cells producing AT1-AA in the pathophysiology of PE.